Literature DB >> 26445397

Beta-blockers and improved survival from ovarian cancer: New miracle treatment or another case of immortal person-time bias?

Sigrun Alba Johannesdottir Schmidt1, Morten Schmidt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26445397     DOI： 10.1002/cncr.29721

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  5 in total

1.  History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.

Authors:  Albina N Minlikeeva; Jo L Freudenheim; Rikki A Cannioto; J Brian Szender; Kevin H Eng; Francesmary Modugno; Roberta B Ness; Michael J LaMonte; Grace Friel; Brahm H Segal; Kunle Odunsi; Paul Mayor; Emese Zsiros; Barbara Schmalfeldt; Rüdiger Klapdor; Thilo Dӧrk; Peter Hillemanns; Linda E Kelemen; Martin Kӧbel; Helen Steed; Anna de Fazio; Susan J Jordan; Christina M Nagle; Harvey A Risch; Mary Anne Rossing; Jennifer A Doherty; Marc T Goodman; Robert Edwards; Keitaro Matsuo; Mika Mizuno; Beth Y Karlan; Susanne K Kjær; Estrid Høgdall; Allan Jensen; Joellen M Schildkraut; Kathryn L Terry; Daniel W Cramer; Elisa V Bandera; Lisa E Paddock; Lambertus A Kiemeney; Leon F Massuger; Jolanta Kupryjanczyk; Andrew Berchuck; Jenny Chang-Claude; Brenda Diergaarde; Penelope M Webb; Kirsten B Moysich
Journal:  Cancer Causes Control       Date:  2017-03-14       Impact factor: 2.506

Review 2.  The Clinical Relevance of Beta Blockers in Ovarian Carcinoma: A Systematic Review.

Authors:  J Hefner; H Csef
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-10       Impact factor: 2.915

3.  Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.

Authors:  Janick Weberpals; Lina Jansen; Myrthe P P van Herk-Sukel; Josephina G Kuiper; Mieke J Aarts; Pauline A J Vissers; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2017-09-01       Impact factor: 8.082

4.  Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation.

Authors:  Yi L Hwa; Qian Shi; Shaji K Kumar; Martha Q Lacy; Morie A Gertz; Prashant Kapoor; Francis K Buadi; Nelson Leung; David Dingli; Ronald S Go; Suzanne R Hayman; Wilson I Gonsalves; Stephen Russell; John A Lust; Yi Lin; S Vincent Rajkumar; Angela Dispenzieri
Journal:  Am J Hematol       Date:  2016-11-18       Impact factor: 10.047

5.  To block it, or not to block it?

Authors:  Artur Wnorowski
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-27       Impact factor: 4.553
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.